Published in Transplantation on January 01, 1987
The first 100 liver transplants at UCLA. Ann Surg (1987) 1.84
Liver transplantation in children. Ann Surg (1991) 1.51
Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc (1987) 1.36
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
A comprehensive review of immunosuppression used for liver transplantation. J Transplant (2009) 0.86
Liver transplantation--the first 25 years. West J Med (1988) 0.76
Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients. Hepat Med (2011) 0.75
Prophylactic use of OKT3 in liver transplantation. A review. Dig Dis Sci (1991) 0.75
Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med (2000) 7.97
Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ (1981) 4.20
Pathogenesis and treatment of gallstones. N Engl J Med (1993) 3.99
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev (1981) 2.78
Effect of polyions on the infectivity of rabies virus in tissue culture: construction of a single-cycle growth curve. J Virol (1967) 2.67
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 2.61
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology (1978) 2.41
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med (1992) 2.36
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16
Mixed cryoglobulinemia responsive to interferon-alpha. Am J Med (1991) 2.15
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
Effective treatment of lymphedema of the extremities. Arch Surg (1998) 2.11
Epidemiology of rabies. Nature (1969) 2.11
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10
Primary biliary cirrhosis. N Engl J Med (1987) 2.06
Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation. Am J Transplant (2013) 2.05
Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature (1980) 1.97
Liver disease associated with early syphilis. N Engl J Med (1971) 1.95
Primary sclerosing cholangitis. N Engl J Med (1995) 1.94
The epidemiology of influenza. Sci Am (1977) 1.90
Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant (2008) 1.87
The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther (2007) 1.85
International practices of organ donation. Br J Anaesth (2012) 1.85
Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull World Health Organ (1971) 1.85
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med (1988) 1.82
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol (1999) 1.77
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer (1997) 1.71
Cystathionine gamma-synthetase of Salmonella. Catalytic properties of a new enzyme in bacterial methionine biosynthesis. J Biol Chem (1966) 1.70
Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation (1999) 1.66
A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology (1994) 1.66
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Experimental infection of weanling pigs with A-swine influenza virus. I. Epidemiology and serological response. Bull World Health Organ (1970) 1.63
Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect (2000) 1.60
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Clinical use of serum enzymes in liver disease. Dig Dis Sci (1988) 1.58
Iron-chelation therapy with oral deferiprone--toxicity or lack of efficacy? N Engl J Med (1998) 1.58
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation (1998) 1.57
Iodothyronine metabolism in rat liver homogenates. J Clin Invest (1978) 1.56
Human influenza A viruses in pigs: isolation of a H3N2 strain antigenically related to A/England/42/72 and evidence for continuous circulation of human viruses in the pig population. Arch Virol (1982) 1.56
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med (1997) 1.54
Experimental infection of weanling pigs with A-swine influenza virus. 2. The shedding of virus by infected animals. Bull World Health Organ (1970) 1.54
Tolerance in a concordant nonhuman primate model. Transplantation (1999) 1.53
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant (2007) 1.51
New strategies needed for treatment of primary biliary cirrhosis? Gastroenterology (1993) 1.51
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation (1996) 1.50
Methotrexate treatment of idiopathic granulomatous hepatitis. Ann Intern Med (1995) 1.50
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst (1990) 1.49
Regional organ preservation program in the New England area. Surgery (1974) 1.47
Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl (2001) 1.46
Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation (1997) 1.45
Surgical management of nonparasitic cystic liver disease. Am J Surg (1991) 1.45
Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest (1970) 1.45
Lymphadenopathy in primary biliary cirrhosis: CT observations. Radiology (1989) 1.45
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation (2001) 1.44
Starvation in the rat. II. Effect of age and obesity on protein sparing and fuel metabolism. Am J Physiol (1980) 1.43
Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg (1988) 1.43
Transesophageal echocardiography reveals an unusual cause of hemodynamic collapse during orthotopic liver transplantation--two case reports. Transplantation (1995) 1.42
Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab (1974) 1.42
In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol (1990) 1.41
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology (1996) 1.41
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4. Bull World Health Organ (1967) 1.39
Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant (2010) 1.39
Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N Engl J Med (1994) 1.39
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol (1987) 1.38
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial. Hepatology (1997) 1.38